ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat cancers: targeted drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called trastuzumab rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. The trial includes 90 participants with three types of cancer: extramammary Paget's disease, rare solid tumors, or ur…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Socks may shield cancer patients from nerve pain
Prevention Recruiting nowThis study tests whether wearing a compression stocking on one foot during chemotherapy can prevent nerve damage (peripheral neuropathy) caused by certain cancer drugs. About 58 adults with advanced bladder or related cancers will participate, with the left foot covered and the r…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: NA • Sponsor: Sheng Zhang • Aim: Prevention
Last updated May 26, 2026 07:12 UTC